BRAIN and NERVE－神経研究の進歩67巻8号

2015年08月発行

特集 神経難病の終末期医療

米国におけるALS末期患者診療の現状—過去10年を省みて

著者： 三本博¹

所属機関： ¹

ページ範囲：P.993 - P.1005

文献概要

10年前に発表したALSの寿命末期（end-of-life：EOL）を改善するための分科会の結論¹⁾をレビューしつつ，その後EOLの各領域でどのような変化・進歩が起こったかを記述した。さらにEOLの特殊な問題，すなわち「故意に死を早めること」と気管切開・人工呼吸器にも言及した。この10年間にほとんどの領域でかなりの進歩がみられたが，現状をレビューすると，ALS患者が「よい死に方」でEOLを終えるためにはさらに多くの改善が必要であることを示している。

参考文献

1) Mitsumoto H, Bromberg M, Johnston W, Tandan R, Byock I, et al: Promoting excellence in end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 6: 145-154, 2005

2) Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, et al: Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52: 1311-1323, 1999

3) Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, et al: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73: 1218-1226, 2009

4) Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, et al: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73: 1227-1233, 2009

5) Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, et al: Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler Other Motor Neuron Disord 8: 195-213, 2007

6) EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, et al: EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol 19: 360-375, 2012

7) Bede P, Oliver D, Stodart J, van den Berg L, Simmons Z, et al: Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. BMJ Support Palliat Care 1: 343-348, 2011

8) Rabkin J, Ogino M, Goetz R, McElhiney M, Marziliano A, et al: Tracheostomy with invasive ventilation for ALS patients: neurologists' roles in the US and Japan. Amyotroph Lateral Scler Frontotemporal Degener 14: 116-123, 2013

9) Mitsumoto H: Amyotrophic Lateral Sclerosis. Patient and Family Guide to Management and Care. 3rd ed. Demos, New York, 2009

10) Bedlack R, Mitsumoto H: Amyotrophic Lateral Sclerosis. A Patient Care Guide for Clinicians. 1st ed. Demos, New York, 2012

11) Williams AL: Perspectives on spirituality at the end of life: a meta-summary. Palliat Support Care 4: 407-417, 2006

12) Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, et al: Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol 15: 1245-1251, 2008

13) Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, et al: Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol 65 (Suppl 1): S24-S28, 2009

14) Adelman EE, Albert SM, Rabkin JG, Del Bene ML, Tider T: Disparities in perceptions of distress and burden in ALS patients and family caregivers. Neurology 62: 1766-1770, 2004

15) Bruletti G, Comini L, Scalvini S, Morini R, Luisa A, et al: A two-year longitudinal study on strain and needs in caregivers of advanced ALS patients. Amyotroph Lateral Scler Frontotemporal Degener 16: 187-195, 2014

16) Rabkin JG, Albert SM, Rowland LP, Mitsumoto H: How common is depression among ALS caregivers? A longitudinal study. Amyotroph Lateral Scler 10: 448-455, 2009

17) Maessen M, Veldink JH, Onwuteaka-Philipsen BD, de Vries JM, Wokke JH, et al: Trends and determinants of end-of-life practices in ALS in the Netherlands. Neurology 73: 954-961, 2009

18) Stutzki R, Schneider U, Reiter-Theil S, Weber M: Attitudes toward assisted suicide and life-prolonging measures in Swiss ALS patients and their caregivers. Front Psychol 3: 443, 2012

19) Fang F, Valdimarsdottir U, Furst CJ, Hultman C, Fall K, et al: Suicide among patients with amyotrophic lateral sclerosis. Brain 131: 2729-2733, 2008

20) Kuhnlein P, Kubler A, Raubold S, Worrell M, Kurt A, et al: Palliative care and circumstances of dying in German ALS patients using non-invasive ventilation. Amyotroph Lateral Scler 9: 91-98, 2008

21) Ganzini L, Silveira MJ, Johnston WS: Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington. J Pain Symptom Manage 24: 312-317, 2002

22) Chio A, Montuschi A, Cammarosano S, De Mercanti S, Cavallo E, et al: ALS patients and caregivers communication preferences and information seeking behaviour. Eur J Neurol 15: 55-60, 2008

23) Schellenberg KL, Schofield SJ, Fang S, Johnston WS: Breaking bad news in amyotrophic lateral sclerosis: the need for medical education. Amyotroph Lateral Scler Frontotemporal Degener 15: 47-54, 2014

24) Elman LB, Stanley L, Gibbons P, McCluskey L: A cost comparison of hospice care in amyotrophic lateral sclerosis and lung cancer. Am J Hosp Palliat Care 23: 212-216, 2006

25) Connolly S, Heslin C, Mays I, Corr B, Normand C: Health and social care costs of managing amyotrophic lateral sclerosis (ALS): an Irish perspective. Amyotroph Lateral Scler Frontotemporal Degener 16: 58-62, 2015

26) Schepelmann K, Winter Y, Spottke AE, Claus D, Grothe C, et al: Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 257: 15-23, 2010

27) Obermann M, Lyon M: Financial cost of amyotrophic lateral sclerosis: a case study. Amyotroph Lateral Scler Frontotemporal Degener 16: 54-57, 2015

28) Gladman M, Dharamshi C, Zinman L: Economic burden of amyotrophic lateral sclerosis: a Canadian study of out-of-pocket expenses. Amyotroph Lateral Scler Frontotemporal Degener 15: 426-432, 2014

29) Jennum P, Ibsen R, Pedersen SW, Kjellberg J: Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study. J Neurol 260: 785-793, 2013

30) Ward AL, Sanjak M, Duffy K, Bravver E, Williams N, et al: Power wheelchair prescription, utilization, satisfaction, and cost for patients with amyotrophic lateral sclerosis: preliminary data for evidence-based guidelines. Arch Phys Med Rehabil 91: 268-272, 2010

31) Bromberg MB, Brownell AA, Forshew DA, Swenson M: A timeline for predicting durable medical equipment needs and interventions for amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler 11: 110-115, 2010

32) van der Steen I, van den Berg JP, Buskens E, Lindeman E, van den Berg LH: The costs of amyotrophic lateral sclerosis, according to type of care. Amyotroph Lateral Scler 10: 27-34, 2009

33) Dubinsky R, Chen J, Lai SM: Trends in hospital utilization and outcome for patients with ALS: analysis of a large U.S. cohort. Neurology 67: 777-780, 2006

34) Vitacca M, Comini L, Assoni G, Fiorenza D, Gile S, et al: Tele-assistance in patients with amyotrophic lateral sclerosis: long term activity and costs. Disabil Rehabil Assist Technol 7: 494-500, 2012

35) Mitsumoto H, Rabkin JG: Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best". JAMA 298: 207-216, 2007

36) McPhee S, Winker M. RM, Pantilat S, Markowtiz A: Care at the Close of Life: evidence and experience. McGraw-Hill Companies, Inc, San Francisco, 2011

37) Bernat JL: Ethical Issues in Neurology. 3rd ed. Lippincott Williams ＆ Wilkins, Philadelphia, 2001

38) Albert SM, Rabkin JG, Del Bene ML, Tider T, O'Sullivan I, et al: Wish to die in end-stage ALS. Neurology 65: 68-74, 2005

39) Rabkin JG, Goetz R, Factor-Litvak P, Hupf J, McElhiney M, et al: Depression and wish to die in a multicenter cohort of ALS patients. Amyotroph Lateral Scler Frontotemporal Degener 16: 265-273, 2015

40) Stutzki R, Weber M, Reiter-Theil S, Simmen U, Borasio GD, et al: Attitudes towards hastened death in ALS: a prospective study of patients and family caregivers. Amyotroph Lateral Scler Frontotemporal Degener 15: 68-76, 2014

41) Albert SM, Whitaker A, Rabkin JG, del Bene M, Tider T, et al: Medical and supportive care among people with ALS in the months before death or tracheostomy. J Pain Symptom Manag 38: 546-553, 2009

42) Rabkin JG, Albert SM, Tider T, Del Bene ML, O'Sullivan I, et al: Predictors and course of elective long-term mechanical ventilation: a prospective study of ALS patients. Amyotroph Lateral Scler 7: 86-95, 2006

43) Rabkin J, Ogino M, Goetz R, McElhiney M, Hupf J, et al: Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey. Amyotroph Lateral Scler Frontotemporal Degener 15: 185-191, 2014

44) Christodoulou G, Goetz R, Ogino M, Mitsumoto H, Rabkin H, et al: Opinions of Japanese and American ALS caregivers regarding tracheostomy with invasive ventilation (TIV). Amyotroph Lateral Scler Frontotemporal Degener, 2015 (in press)